Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment

NCT02901392 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-08-02

No results posted yet for this study

Summary

Stress urinary incontinence is a significant potential source of morbidity after radical prostatectomy or radiation therapy for prostate cancer. At present, artificial urinary sphincter remains the preferred therapeutic option. However, this technique is not free from complications. In an attempt to avoid such complications, male sling has been suggested for use in patients with mild degrees of stress incontinence.

Conditions

  • Urinary Incontinence, Stress

Interventions

PROCEDURE

AMS-800

Artificial urianry sphincter

PROCEDURE

ADVANCE/ADVANCEXP

Male sling

PROCEDURE

VIRTUE

Male sling

PROCEDURE

INVANCE

Male sling

Sponsors & Collaborators

  • Fundación Instituto Valenciano de Oncología

    lead OTHER

Principal Investigators

  • Argimiro Collado, MD,PhD · Fundación IVO

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2019-04-30
Completion
2031-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02901392 on ClinicalTrials.gov